MS
Megha Sanjay Jain
About Megha Sanjay Jain
Data last updated:
Megha Sanjay Jain is an Additional Director at Samrat Pharmachem Limited (since 2024). The company operates in Chemicals and Materials. Samrat Pharmachem Limited reported revenue of ₹287 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Samrat Pharmachem Limited L24230GJ1992PLC017820 | Additional Director | 01 Aug 2024 | 1992 | ₹287 Cr (FY 2025) | Active |
Board colleagues of Megha Sanjay Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Lalit Damodar Mehta | 00216681 | Samrat Pharmachem Limited | Managing Director |
| Manishkumar Indukumar Pipalia | 00376313 | Samrat Pharmachem Limited | Director |
| Megh Rajesh Mehta | 07287394 | Samrat Pharmachem Limited | Whole-Time Director |
| Nishant Kumar Kankaria | Samrat Pharmachem Limited | Company Secretary | |
| Piyush Gangji Dharod | 11119391 | Samrat Pharmachem Limited | Director |
| Rajesh Lalit Mehta | 00216731 | Samrat Pharmachem Limited | Whole-Time Director |
| Rajesh Lalit Mehta | Samrat Pharmachem Limited | Cfo | |
| Sachin Samir Kothary | 10470497 | Samrat Pharmachem Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Megha Sanjay Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Megha Sanjay Jain
Megha Sanjay Jain currently holds 1 directorship: Samrat Pharmachem Limited (Additional Director, since 01 Aug 2024, revenue ₹287 Cr (FY 2025)).
Megha Sanjay Jain was first appointed on 01 Aug 2024 as Additional Director at Samrat Pharmachem Limited.
The current boards of Megha Sanjay Jain's companies include Lalit Damodar Mehta (Samrat Pharmachem Limited), Manishkumar Indukumar Pipalia (Samrat Pharmachem Limited), Megh Rajesh Mehta (Samrat Pharmachem Limited), Nishant Kumar Kankaria (Samrat Pharmachem Limited), Piyush Gangji Dharod (Samrat Pharmachem Limited), Rajesh Lalit Mehta (Samrat Pharmachem Limited), among others.